Literature DB >> 25133965

Optical coherence tomography in papilledema: what am I missing?

Randy Kardon1.   

Abstract

BACKGROUND: Grading of papilledema severity is subjective and based on monocular fundus features of the optic nerve. Interobserver agreement on grading the severity of papilledema is poor among expert observers, even using well-defined criteria such as the Frisen scale, which is a non-continuous ordinal scale of grading. Furthermore, non-expert clinicians often find it difficult to properly view and interpret features of the optic nerve using ophthalmoscopy, which can lead to failure to diagnose papilledema in non-ophthalmologic care settings. This may delay treatment, which can result in vision loss. Distinguishing papilledema from pseudopapilledema can also be difficult when surface drusen are not easily identified. Once papilledema is diagnosed, it is often difficult to determine whether a reduction in optic nerve edema is due solely to improvement in the status of the nerve or whether this represents concomitant loss of axons and viable retinal ganglion cells, leading to a poor visual outcome. Timely advancement of treatment would occur if loss of neurons could be diagnosed at an earlier stage of evaluation while optic disc edema is still present. This review will critically assess the role of optical coherence tomography (OCT) in solving these problems by providing an advanced imaging approach for diagnosis of papilledema and evaluating its severity on a continuous scale and evaluating the causes of visual loss in the setting of a swollen nerve. METHODS ACQUISITION: The published literature (PubMed) was reviewed from 2000 to 2014 on the use of OCT for diagnosing papilledema, differentiating it from pseudopapilledema, providing a continuous scale of its severity and in evaluating causes of visual loss.
RESULTS: Recent evidence shows that OCT analysis of the retinal nerve fiber layer and retinal ganglion cell layer in papilledema can be associated with misleading artifacts due to layer segmentation failures. Newer 3D algorithms using neighboring locations help to overcome these problems. Disc volume appears to be a promising continuous measure of papilledema that is robust and has less associated artifacts. Buried optic disc drusen can be identified using enhanced depth OCT imaging, but recent studies have shown poor ability to differentiate papilledema from pseudopapilledema using OCT when the degree of disc evaluation is similar. Analysis of the retinal ganglion cell layer shows promise of early detection of vision loss due to neuronal injury. Subretinal fluid is easily identified with OCT and can help to identify a potentially reversible component of vision loss. Newer OCT imaging methods will allow the definition of capillaries and flow within them in and around the optic nerve head.
CONCLUSIONS: Currently, the most useful OCT derived features relevant to papilledema are disc volume, subretinal fluid, buried disc drusen, and thickness of the retinal ganglion cell layer.

Entities:  

Mesh:

Year:  2014        PMID: 25133965     DOI: 10.1097/WNO.0000000000000162

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  16 in total

Review 1.  Current concepts and strategies in the diagnosis and management of idiopathic intracranial hypertension in adults.

Authors:  Jane W Chan
Journal:  J Neurol       Date:  2017-01-31       Impact factor: 4.849

2.  Macular Ganglion Cell Layer and Peripapillary Retinal Nerve Fibre Layer Thickness in Patients with Unilateral Posterior Cerebral Artery Ischaemic Lesion: An Optical Coherence Tomography Study.

Authors:  Rita Anjos; Luisa Vieira; Livio Costa; André Vicente; Arnaldo Santos; Nuno Alves; Duarte Amado; Joana Ferreira; João Paulo Cunha
Journal:  Neuroophthalmology       Date:  2016-01-19

3.  Use of A-scan Ultrasound and Optical Coherence Tomography to Differentiate Papilledema From Pseudopapilledema.

Authors:  Roberto Saenz; Han Cheng; Thomas C Prager; Laura J Frishman; Rosa A Tang
Journal:  Optom Vis Sci       Date:  2017-12       Impact factor: 1.973

Review 4.  Optical Coherence Tomography to Differentiate Papilledema from Pseudopapilledema.

Authors:  Gema Rebolleda; Aki Kawasaki; Victoria de Juan; Noelia Oblanca; Francisco Jose Muñoz-Negrete
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-17       Impact factor: 5.081

5.  Digital Phenotyping in Clinical Neurology.

Authors:  Anoopum S Gupta
Journal:  Semin Neurol       Date:  2022-01-11       Impact factor: 3.212

6.  Volumetric Measurement of Optic Nerve Head Drusen Using Swept-Source Optical Coherence Tomography.

Authors:  Edem Tsikata; Alice C Verticchio Vercellin; Iryna Falkenstein; Linda Yi-Chieh Poon; Stacey Brauner; Ziad Khoueir; John B Miller; Teresa C Chen
Journal:  J Glaucoma       Date:  2017-09       Impact factor: 2.503

Review 7.  Optic disk drusen in children.

Authors:  Melinda Y Chang; Stacy L Pineles
Journal:  Surv Ophthalmol       Date:  2016-03-29       Impact factor: 6.048

8.  Evaluation of Optical Coherence Tomography to Detect Elevated Intracranial Pressure in Children.

Authors:  Jordan W Swanson; Tomas S Aleman; Wen Xu; Gui-Shuang Ying; Wei Pan; Grant T Liu; Shih-Shan Lang; Gregory G Heuer; Phillip B Storm; Scott P Bartlett; William R Katowitz; Jesse A Taylor
Journal:  JAMA Ophthalmol       Date:  2017-04-01       Impact factor: 7.389

9.  Accuracy of a Deep Learning System for Classification of Papilledema Severity on Ocular Fundus Photographs.

Authors:  Caroline Vasseneix; Raymond P Najjar; Xinxing Xu; Zhiqun Tang; Jing Liang Loo; Shweta Singhal; Sharon Tow; Leonard Milea; Daniel Shu Wei Ting; Yong Liu; Tien Y Wong; Nancy J Newman; Valerie Biousse; Dan Milea
Journal:  Neurology       Date:  2021-05-19       Impact factor: 9.910

10.  Utility of Spectral-Domain Optical Coherence Tomography in Differentiating Papilledema From Pseudopapilledema: A Prospective Longitudinal Study.

Authors:  Imran Jivraj; Cesar A Cruz; Maxwell Pistilli; Anita A Kohli; Grant T Liu; Kenneth S Shindler; Robert A Avery; Mona K Garvin; Jui-Kai Wang; Ahmara Ross; Madhura A Tamhankar
Journal:  J Neuroophthalmol       Date:  2021-12-01       Impact factor: 4.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.